Biotech ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV(TM) & BIVIGAM® December 13, 2022
Biotech ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2022 December 13, 2022
Biotech Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm December 12, 2022
Biotech Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR) December 12, 2022
Biotech Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition December 12, 2022
Biotech Curis Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS December 12, 2022
Biotech Affimed Presents Updated Data for AFM28 Demonstrating Efficient Elimination of Leukemic Stem and Progenitor Cells in Combination with Allogeneic NK cells in Preclinical Models of Acute Myeloid Leukemia and Myelodysplastic Syndrome at the Annual ASH 2022 Meeting December 12, 2022
Biotech Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR) Encourages Long-Term EIGR Investors to Contact the Firm December 12, 2022
Biotech (Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation December 12, 2022
Biotech Actinium Highlights Survival Data in Relapsed/Refractory AML Patients with Prior Venetoclax Treatment and/or with a TP53 Mutation from the Actimab-A CLAG-M Combination Trial Oral Presentation at ASH December 12, 2022